EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Marine-Derived Polysaccharides Against Ulcerative Colitis: Sources, Structures, and Multi-Target Mechanisms

Dandan Zheng, Xuefei Wang, Yudi Xiang, Shuoshi Wei, Ruihua Chen, Qiang Lu, Cailan Li

Marine Drugs · 23.09.2026 · 24 (10) · 332

DOI: 10.3390/md24100332 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Marine Drugs, online erschienen am 23.09.2026. Verfasst von Dandan Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Zunyi Medical University, Zhuhai Campus, Zhuhai 519041, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Polysaccharides, Aquatic Organisms, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Projects of Guizhou Province, Future “Science and Technology Elite” Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Marine-derived polysaccharides have emerged as promising bioactive candidates for alleviating ulcerative colitis (UC), a chronic inflammatory bowel disease with limited therapeutic options. This review systematically summarizes recent advances in the sources, preparation methods, structural features, and multi-target mechanisms of these polysaccharides from seaweeds, marine animals, and microorganisms. Key physicochemical parameters, including molecular weight, monosaccharide composition, glycosidic linkages, and sulfation patterns, critically influence their anti-colitis efficacy. Mechanistically, these macromolecules synergistically restore gut microbiota homeostasis (e.g., promoting short-chain fatty acids and secondary bile acids), suppress inflammatory pathways (NF-κB, MAPK, and NLRP3), regulate immune responses (inhibiting dendritic cell and Th1/Th17 activation), alleviate oxidative stress via the Nrf2/HO-1 pathway, and reinforce intestinal epithelial barrier integrity (upregulating tight junction proteins and mucins). Although systematic toxicological characterization remains limited, the generally favorable safety profiles reported in preclinical studies, together with their multi-target nature, suggest that marine polysaccharides hold great potential as functional foods or adjunctive therapies for UC. However, challenges remain in structural heterogeneity, batch-to-batch consistency, and limited clinical validation. Future efforts should prioritize structure–activity relationship elucidation, advanced analytical characterization, bioavailability and gastrointestinal fate studies, standardization and quality control, comparative evaluation against conventional therapies and other natural products, and well-designed clinical trials to facilitate translation from bench to bedside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativePolysaccharidesAquatic OrganismsAnti-Inflammatory AgentsHumansAnimalsSeaweedGastrointestinal MicrobiomeStructure-Activity Relationship

Stichwörter der Autor:innen

extractionmarine polysaccharidesmolecular mechanismstructural featuresulcerative colitis

Substanzen

PolysaccharidesAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmacology, Zunyi Medical University, Zhuhai Campus, Zhuhai 519041, China.
  • Department of Pharmaceutical Sciences, Zunyi Medical University, Zhuhai Campus, Zhuhai 519041, China.
  • Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563000, China.
  • Key Laboratory of Basic Pharmacology of Guizhou Province and School of Pharmacy, Zunyi Medical University, Zunyi 563000, China.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Projects of Guizhou Province
  • Future “Science and Technology Elite” Project

Zitieren

APA

Zheng, D., Wang, X., Xiang, Y., Wei, S., Chen, R., Lu, Q., & Li, C. (2026). Marine-Derived Polysaccharides Against Ulcerative Colitis: Sources, Structures, and Multi-Target Mechanisms. Marine Drugs, 24(10), 332. https://doi.org/10.3390/md24100332

Vancouver

Zheng D, Wang X, Xiang Y, Wei S, Chen R, Lu Q, et al. Marine-Derived Polysaccharides Against Ulcerative Colitis: Sources, Structures, and Multi-Target Mechanisms. Marine Drugs. 2026;24(10):332. doi:10.3390/md24100332

BibTeX
@article{Zheng2026,
  author = {Zheng, Dandan and Wang, Xuefei and Xiang, Yudi and Wei, Shuoshi and Chen, Ruihua and Lu, Qiang and Li, Cailan},
  title = {Marine-Derived Polysaccharides Against Ulcerative Colitis: Sources, Structures, and Multi-Target Mechanisms},
  journal = {Marine Drugs},
  year = {2026},
  volume = {24},
  number = {10},
  pages = {332},
  doi = {10.3390/md24100332}
}
Kostenlos starten →